Insight Molecular Diagnostics Inc. (IMDX) Financials

IMDX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 40.4 million 51.1 million
Dec. 31, 2025 25.8 million 57.2 million
Sept. 30, 2025 43.9 million 53.1 million
June 30, 2025 50.5 million 49.4 million

IMDX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -8.3 million 615000
Dec. 31, 2025 -7.0 million 721000
Sept. 30, 2025 -5.6 million 559000
June 30, 2025 -6.6 million 504000

IMDX Net Income

No data available :(

IMDX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 28.2 million 1.3 million 3.1 million
Dec. 31, 2025 11.6 million - 3.5 million
Sept. 30, 2025 18.7 million 1.5 million 3.1 million
June 30, 2025 24.3 million - 3.4 million

IMDX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 34.5 million
Dec. 31, 2025 30.5 million
Sept. 30, 2025 32.0 million
June 30, 2025 32.0 million

IMDX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 613000 4.6 million 5.4 million 2.4 million
Dec. 31, 2025 1.5 million 5.8 million 4.4 million 385000
Sept. 30, 2025 1.1 million 3.9 million 3.9 million 1.4 million
June 30, 2025 349000 3.3 million 4.1 million 1.5 million

IMDX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 32000 637500
Dec. 31, 2025 1.1 million 643000
Sept. 30, 2025 260000 121000
June 30, 2025 518000 168000

IMDX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

IMDX

Price: $6.03

52 week price:
2.33
8.51

Earnings Per Share: -1.51 USD

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Market Capitalization: 161.9 million

Links: